“PatientsForce stands for the Force that supports patients, using patients as the starting point to fill the gap in health insurance benefits with market supply and demand.” Xiangxin Zhang, General Manager of Photography Strategy, said, “PatientsForce has established a medical benefit plan platform for mutual benefit between doctors and patients, which is not a drug procurement platform, but a patient-centered medication application management, and helps cancer or special medication patients reduce financial toxicity through drug benefit plans supported by pharmaceutical companies or third parties.”
PatientsForce Wins Visionary ESG Corporate Sustainable Social Innovation Award
(Taipei, May 1, 2024) – PatientsForce, a digital management platform service based on strategic advisors, was today awarded the SME Award in the Social Innovation category of the 20th Global ESG Corporate Sustainability Awards, in recognition of the company’s impact value in social innovation.
The PatientsForce Patient Support Program focuses on providing patient support programs for self-financed new drugs, reducing the financial burden on patients, providing patient-centered companion care, and serving tens of thousands of cancer and specialty medication patients annually through a digital management platform for case management.
The financial burden of new cancer drugs has become a major issue in society
The financial burden of new cancer drugs has become one of the major social issues that Taiwan urgently needs to solve. According to a survey by the Taiwan Cancer Foundation, as many as 66% of cancer patients pay more than 300,000 yuan for medical expenses, and 20% of them pay more than 1 million yuan out of pocket. Such financial pressure not only seriously affects the quality of life of patients, but also directly affects the treatment effect, and may even lead to the inability of patients to obtain complete treatment.
In recent years, due to the leapfrog progress in medical technology, the speed of launching new drugs or medical materials has accelerated, and although new drugs are a new choice for doctors and patients, they may also be a heavy financial burden if they are not covered by insurance. In particular, with the rising cost of R&D and marketing of new drugs launched recently, in addition to the cooperation of public and private insurance to establish a more complete social medical protection network, the Patient Assistance Program using the market free contract mechanism to provide drug support model provided by pharmaceutical foundations or third parties is also a global market development trend and an important ESG issue for pharmaceutical companies.
PatientsForce Innovative Solutions provides affordable new drug support management
In 2015, the strategy invested in the development of the patient support plan system, and in 2021, it was awarded the Digital Health Industry Application Seal of the National Medical Quality Award by the Medical Policy Council, and through continuous investment in system research and development and optimization of corporate governance, it has provided new drug support services to nearly 60 international pharmaceutical companies, reducing the drug burden of patients by more than 5 billion yuan. In addition, more than 40,000 cancer patients have benefited from the care team and smart healthcare system.
“PatientsForce plays the role of a hub, and when patients are faced with difficult treatment, it is hard enough to help, and they need practical resources to help.” “We hope that through innovative business models and digital tools, resource providers, such as pharmaceutical companies and other stakeholders, can more efficiently switch to patients. When a new drug enters the health insurance payment, our phased tasks are completed and converted to the next phase of accompanying care services.”
Innovative services are internationally recognized and we continue to explore more possibilities
The PatientsForce patient support management platform is not just a digital system, but also includes the corporate responsibility practices of the company’s ESG approach to the collection strategy. In addition to joining the international carbon neutrality target agreement, the strategy has continuously invested in R&D to optimize the management process and use digital tools to reduce carbon emissions. In addition, it has obtained ISO 9001, 27001, 27701 certification related to the patient support plan system, and spared no effort to invest in the management system of patient safety.
“We don’t want to see people poor due to illness, but we also hope that medical equality can take into account patients with different affordability, and encourage innovation to pursue better medical care and health quality, which are the values of the United Nations’ 17 Sustainable Development Goals.” General Manager Zhang said, “All resources come from the needs of patients, and the market forces that are motivated to provide resources to patients will be the most motivated to implement the SDGs concept.”
【About Caihong Health Integration Group】
Caihong Health Integration Group/Caihong Health Holdings, including Caihong Integrated Marketing, Caifeng Strategic Consulting, Caiyao Biomedical Technology, Caifeng Health E-commerce, and Anjie Chuangsheng, has created the PatientsForce patient benefit plan management platform, focusing on the digitalization and management innovation of pharmaceutical value-added services, and realizing the vision of helping everyone obtain health and complete treatment.
Irene Ku, Director, Integrated Marketing Co., Ltd
